Bai Y, et al. - Researchers contemplated the role and safety of adjuvant therapy in locally advanced renal cell carcinoma (RCC). No survival benefit was gained through the inclusion of adjuvant therapy. Nevertheless, it increased the rates of adverse events for locally advanced RCC patients.